0001668397-24-000021.txt : 20240223
0001668397-24-000021.hdr.sgml : 20240223
20240223161129
ACCESSION NUMBER: 0001668397-24-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Troendle August J.
CENTRAL INDEX KEY: 0001622058
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37856
FILM NUMBER: 24671267
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medpace Holdings, Inc.
CENTRAL INDEX KEY: 0001668397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 320434904
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
BUSINESS PHONE: (513) 579-9911
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
4
1
wk-form4_1708722670.xml
FORM 4
X0508
4
2024-02-21
0
0001668397
Medpace Holdings, Inc.
MEDP
0001622058
Troendle August J.
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
CINCINNATI
OH
45227
1
1
1
0
CEO
0
Common Stock
2024-02-21
4
S
0
36012
383.44
D
5489947
I
By Medpace Investors, LLC
Common Stock
2024-02-22
4
S
0
100000
395.98
D
5389947
I
By Medpace Investors, LLC
Common Stock
806643
D
The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $379.96 to $386.56. The Reporting Person undertakes to provide full pricing information to
the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.86 to $401.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
2024-02-23